Skip to main content
Signal8
Roth David profile photo

David Roth

CIK: 0001599014

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Syros Pharmaceuticals, Inc. logo
SYRS

Syros Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Nov 18, 2024
    Sale(S)
    Direct
    12.1K shares at avg. $0.20$2K
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Oct 31, 2024
    Exercise(M)
    Direct
    18.9K shares-
  • Syros Pharmaceuticals, Inc. logo
    SYRS

    Syros Pharmaceuticals, Inc.

    Oct 31, 2024
    Tax Payment(F)
    Direct
    6.8K shares at avg. $2.09$14K

1-3 of 3

David Roth files insider reports with the SEC as Chief Medical Officer of Syros Pharmaceuticals, Inc. (SYRS). Signal8 holds 3 reported Form 4/5 transactions by David Roth since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in SYRS, dated Nov 18, 2024.

About Roth David

Roth David (SEC CIK 0001599014) files insider reports with the SEC as Chief Medical Officer of Syros Pharmaceuticals, Inc. (SYRS).

Signal8 holds 2 ownership filings by Roth David, all Form 4s, filed between Nov 4, 2024 and Nov 20, 2024. Those filings report 3 transactions, from Oct 31, 2024 to Nov 18, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Roth David's filings is in CAMBRIDGE, MA.

Recent filings by Roth David

  • Nov 18, 2024: Open-market sale of SYRS shares (Form 4, code S).
  • Oct 31, 2024: Option exercise of SYRS shares (Form 4, code M).
  • Oct 31, 2024: Tax withholding of SYRS shares (Form 4, code F).

Other insiders filing for Syros Pharmaceuticals, Inc. (SYRS)

How to read Form 4 transaction codes